Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Research Report 2023
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
Affecting 70-80% of patients undergoing chemotherapy, chemotherapy-induced nausea and vomiting (CINV) is one of chemotherapy's most debilitating side effects, often attributed as a leading cause of premature discontinuation of cancer treatment.
Highlights
The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs key players include Haisco, Merck, Mundipharma, Qilu Pharma, Heron Therapeutics, Teva, etc. Global top six manufacturers hold a share about 30%.
North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, both have a share about 60 percent.
In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 70%. And in terms of application, the largest application is Acute CINV, followed by Delayed CINV and Breakthrough CINV.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs.
The Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market.
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Affecting 70-80% of patients undergoing chemotherapy, chemotherapy-induced nausea and vomiting (CINV) is one of chemotherapy's most debilitating side effects, often attributed as a leading cause of premature discontinuation of cancer treatment.
Highlights
The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs key players include Haisco, Merck, Mundipharma, Qilu Pharma, Heron Therapeutics, Teva, etc. Global top six manufacturers hold a share about 30%.
North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, both have a share about 60 percent.
In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 70%. And in terms of application, the largest application is Acute CINV, followed by Delayed CINV and Breakthrough CINV.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs.
The Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Heron Therapeutics
- Merck
- Eisai
- Mundipharma
- Qilu Pharma
- Teva
- Novartis
- Roche
- Mylan
- Baxter
- GSK
- Helsinn
- Southwest Pharma
- Haisco
- Sun Pharma
Global markets are presented by Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs segment by Type
- 5-HT3 Inhibitors
- NK1 Inhibitors
- Others
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market.
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs segment by Application
- Acute CINV
- Delayed CINV
- Breakthrough CINV
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
- Which product segment grabbed the largest share in the Product Name market?
- How is the competitive scenario of the Product Name market?
- Which are the key factors aiding the Product Name market growth?
- Which are the prominent players in the Product Name market?
- Which region holds the maximum share in the Product Name market?
- What will be the CAGR of the Product Name market during the forecast period?
- Which application segment emerged as the leading segment in the Product Name market?
- What key trends are likely to emerge in the Product Name market in the coming years?
- What will be the Product Name market size by 2028?
- Which company held the largest share in the Product Name market?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) of Manufacturers (2018-2023)
Table 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue of Manufacturers (2018-2023)
Table 9. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Heron Therapeutics Company Information
Table 17. Heron Therapeutics Business Overview
Table 18. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 20. Heron Therapeutics Recent Developments
Table 21. Merck Company Information
Table 22. Merck Business Overview
Table 23. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 25. Merck Recent Developments
Table 26. Eisai Company Information
Table 27. Eisai Business Overview
Table 28. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 30. Eisai Recent Developments
Table 31. Mundipharma Company Information
Table 32. Mundipharma Business Overview
Table 33. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 35. Mundipharma Recent Developments
Table 36. Qilu Pharma Company Information
Table 37. Qilu Pharma Business Overview
Table 38. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 40. Qilu Pharma Recent Developments
Table 41. Teva Company Information
Table 42. Teva Business Overview
Table 43. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 45. Teva Recent Developments
Table 46. Novartis Company Information
Table 47. Novartis Business Overview
Table 48. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 50. Novartis Recent Developments
Table 51. Roche Company Information
Table 52. Roche Business Overview
Table 53. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 55. Roche Recent Developments
Table 56. Mylan Company Information
Table 57. Mylan Business Overview
Table 58. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 60. Mylan Recent Developments
Table 61. Baxter Company Information
Table 62. Baxter Business Overview
Table 63. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 64. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 65. Baxter Recent Developments
Table 66. GSK Company Information
Table 67. GSK Business Overview
Table 68. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 69. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 70. GSK Recent Developments
Table 71. Helsinn Company Information
Table 72. Helsinn Business Overview
Table 73. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 74. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 75. Helsinn Recent Developments
Table 76. Southwest Pharma Company Information
Table 77. Southwest Pharma Business Overview
Table 78. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 79. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 80. Southwest Pharma Recent Developments
Table 81. Haisco Company Information
Table 82. Haisco Business Overview
Table 83. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 85. Haisco Recent Developments
Table 86. Sun Pharma Company Information
Table 87. Sun Pharma Business Overview
Table 88. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 90. Sun Pharma Recent Developments
Table 91. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 92. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2018-2023) & (M Units)
Table 93. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2018-2023)
Table 94. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2024-2029) & (M Units)
Table 95. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2024-2029)
Table 96. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 97. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2018-2023)
Table 98. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 99. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2024-2029)
Table 100. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2018-2023) & (M Units)
Table 102. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2024-2029) & (M Units)
Table 103. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 104. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 105. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2018-2023) & (M Units)
Table 107. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2024-2029) & (M Units)
Table 108. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 109. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 110. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2018-2023) & (M Units)
Table 112. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2024-2029) & (M Units)
Table 113. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 114. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 115. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2018-2023) & (M Units)
Table 117. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2024-2029) & (M Units)
Table 118. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 119. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 120. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2018-2023) & (M Units)
Table 122. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2024-2029) & (M Units)
Table 123. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 124. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 125. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2018-2023) & (M Units)
Table 126. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2024-2029) & (M Units)
Table 127. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2018-2023)
Table 128. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2024-2029)
Table 129. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 130. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 131. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2018-2023)
Table 132. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2024-2029)
Table 133. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2018-2023) & (US$/Unit)
Table 134. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2024-2029) & (US$/Unit)
Table 135. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2018-2023) & (M Units)
Table 136. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2024-2029) & (M Units)
Table 137. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2018-2023)
Table 138. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2024-2029)
Table 139. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 140. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 141. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2018-2023)
Table 142. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2024-2029)
Table 143. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2018-2023) & (US$/Unit)
Table 144. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2024-2029) & (US$/Unit)
Table 145. Key Raw Materials
Table 146. Raw Materials Key Suppliers
Table 147. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors List
Table 148. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers List
Table 149. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Trends
Table 150. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Drivers
Table 151. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Restraints
Table 152. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) of Manufacturers (2018-2023)
Table 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue of Manufacturers (2018-2023)
Table 9. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Heron Therapeutics Company Information
Table 17. Heron Therapeutics Business Overview
Table 18. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 20. Heron Therapeutics Recent Developments
Table 21. Merck Company Information
Table 22. Merck Business Overview
Table 23. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 25. Merck Recent Developments
Table 26. Eisai Company Information
Table 27. Eisai Business Overview
Table 28. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 30. Eisai Recent Developments
Table 31. Mundipharma Company Information
Table 32. Mundipharma Business Overview
Table 33. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 35. Mundipharma Recent Developments
Table 36. Qilu Pharma Company Information
Table 37. Qilu Pharma Business Overview
Table 38. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 40. Qilu Pharma Recent Developments
Table 41. Teva Company Information
Table 42. Teva Business Overview
Table 43. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 45. Teva Recent Developments
Table 46. Novartis Company Information
Table 47. Novartis Business Overview
Table 48. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 50. Novartis Recent Developments
Table 51. Roche Company Information
Table 52. Roche Business Overview
Table 53. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 55. Roche Recent Developments
Table 56. Mylan Company Information
Table 57. Mylan Business Overview
Table 58. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 60. Mylan Recent Developments
Table 61. Baxter Company Information
Table 62. Baxter Business Overview
Table 63. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 64. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 65. Baxter Recent Developments
Table 66. GSK Company Information
Table 67. GSK Business Overview
Table 68. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 69. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 70. GSK Recent Developments
Table 71. Helsinn Company Information
Table 72. Helsinn Business Overview
Table 73. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 74. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 75. Helsinn Recent Developments
Table 76. Southwest Pharma Company Information
Table 77. Southwest Pharma Business Overview
Table 78. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 79. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 80. Southwest Pharma Recent Developments
Table 81. Haisco Company Information
Table 82. Haisco Business Overview
Table 83. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 85. Haisco Recent Developments
Table 86. Sun Pharma Company Information
Table 87. Sun Pharma Business Overview
Table 88. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
Table 90. Sun Pharma Recent Developments
Table 91. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 92. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2018-2023) & (M Units)
Table 93. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2018-2023)
Table 94. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2024-2029) & (M Units)
Table 95. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2024-2029)
Table 96. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 97. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2018-2023)
Table 98. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 99. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2024-2029)
Table 100. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2018-2023) & (M Units)
Table 102. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2024-2029) & (M Units)
Table 103. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 104. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 105. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2018-2023) & (M Units)
Table 107. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2024-2029) & (M Units)
Table 108. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 109. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 110. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2018-2023) & (M Units)
Table 112. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2024-2029) & (M Units)
Table 113. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 114. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 115. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2018-2023) & (M Units)
Table 117. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2024-2029) & (M Units)
Table 118. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 119. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 120. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2018-2023) & (M Units)
Table 122. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2024-2029) & (M Units)
Table 123. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 124. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 125. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2018-2023) & (M Units)
Table 126. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2024-2029) & (M Units)
Table 127. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2018-2023)
Table 128. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2024-2029)
Table 129. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 130. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 131. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2018-2023)
Table 132. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2024-2029)
Table 133. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2018-2023) & (US$/Unit)
Table 134. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2024-2029) & (US$/Unit)
Table 135. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2018-2023) & (M Units)
Table 136. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2024-2029) & (M Units)
Table 137. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2018-2023)
Table 138. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2024-2029)
Table 139. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 140. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 141. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2018-2023)
Table 142. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2024-2029)
Table 143. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2018-2023) & (US$/Unit)
Table 144. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2024-2029) & (US$/Unit)
Table 145. Key Raw Materials
Table 146. Raw Materials Key Suppliers
Table 147. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors List
Table 148. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers List
Table 149. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Trends
Table 150. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Drivers
Table 151. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Restraints
Table 152. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Chemotheraphy Induced Nausea and Vomitting (CINV) DrugsProduct Picture
Figure 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (2018-2029) & (US$ Million)
Figure 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (2018-2029) & (M Units)
Figure 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price (US$/Unit) & (2018-2029)
Figure 9. 5-HT3 Inhibitors Product Picture
Figure 10. NK1 Inhibitors Product Picture
Figure 11. Others Product Picture
Figure 12. Acute CINV Product Picture
Figure 13. Delayed CINV Product Picture
Figure 14. Breakthrough CINV Product Picture
Figure 15. Others Product Picture
Figure 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Manufacturers in 2022
Figure 17. Global Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Manufacturing Sites & Headquarters
Figure 18. Global Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players Market Share by Revenue in 2022
Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region in 2022
Figure 23. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region in 2022
Figure 24. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country in 2022
Figure 25. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2018-2029)
Figure 26. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2018-2029)
Figure 27. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country in 2022
Figure 30. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2018-2029)
Figure 31. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2018-2029)
Figure 32. Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country in 2022
Figure 38. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2018-2029)
Figure 39. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2018-2029)
Figure 40. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. China Taiwan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country in 2022
Figure 50. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2018-2029)
Figure 51. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2018-2029)
Figure 52. Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Argentina Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country in 2022
Figure 56. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2018-2029)
Figure 57. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2018-2029)
Figure 58. Turkey Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. UAE Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2018-2029)
Figure 62. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2018-2029)
Figure 63. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Type (2018-2029)
Figure 64. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2018-2029)
Figure 65. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2018-2029)
Figure 66. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Application (2018-2029)
Figure 67. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Value Chain
Figure 68. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Chemotheraphy Induced Nausea and Vomitting (CINV) DrugsProduct Picture
Figure 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (2018-2029) & (US$ Million)
Figure 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (2018-2029) & (M Units)
Figure 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price (US$/Unit) & (2018-2029)
Figure 9. 5-HT3 Inhibitors Product Picture
Figure 10. NK1 Inhibitors Product Picture
Figure 11. Others Product Picture
Figure 12. Acute CINV Product Picture
Figure 13. Delayed CINV Product Picture
Figure 14. Breakthrough CINV Product Picture
Figure 15. Others Product Picture
Figure 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Manufacturers in 2022
Figure 17. Global Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Manufacturing Sites & Headquarters
Figure 18. Global Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players Market Share by Revenue in 2022
Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region in 2022
Figure 23. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region in 2022
Figure 24. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country in 2022
Figure 25. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2018-2029)
Figure 26. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2018-2029)
Figure 27. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country in 2022
Figure 30. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2018-2029)
Figure 31. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2018-2029)
Figure 32. Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country in 2022
Figure 38. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2018-2029)
Figure 39. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2018-2029)
Figure 40. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. China Taiwan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country in 2022
Figure 50. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2018-2029)
Figure 51. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2018-2029)
Figure 52. Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Argentina Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country in 2022
Figure 56. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2018-2029)
Figure 57. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2018-2029)
Figure 58. Turkey Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. UAE Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2018-2029)
Figure 62. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2018-2029)
Figure 63. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Type (2018-2029)
Figure 64. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2018-2029)
Figure 65. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2018-2029)
Figure 66. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Application (2018-2029)
Figure 67. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Value Chain
Figure 68. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Opportunities and Challenges
